Search Results

Professor Lin Guoxian from the BC Cancer Agency Delivers Academic Exchange at the Institute of Radiation Medicine, Chinese Academy of Medical Sciences

Lin Guoxian: Professor at the BC Cancer Agency, whose research focuses on the development of targeted radiopharmaceuticals for the diagnosis and treatment of various tumors. To date, he has led/participated in the publication of over 135 peer-reviewed journal articles, filed more than 30 patent applications related to radiopharmaceuticals, and completed the clinical translation of 7 self-developed radiopharmaceuticals for the diagnosis and treatment of multiple tumor types. During the seminar, Professor Lin Guoxian, based on his team's years of frontier exploration, systematically reviewed the research progress of nuclear drugs targeting PSMA for prostate cancer: first, the molecular design and clinical advantages of F-18 labeled PSMA-targeted PET imaging agents; second, the substantial improvement of tumor targeting of Lu-177 labeled therapeutic radiopharmaceuticals through rational optimization of molecular structures,...

2026-08-07

Container Non-Opening Inspection and Screening System Commissioned at Logistics Center in Moscow Oblast, Russia

According to the press service of the Moscow Oblast Ministry of Investment, Industry and Science, the Selyatino Transport and Logistics Center (TLC), located in the Naro-Fominsk urban district of Moscow Oblast, Russia, has installed a modern inspection and screening facility to improve the efficiency of container cargo inspection and the level of transport safety. The equipment enables rapid inspection of cargo inside containers without opening them, helping staff determine whether dangerous goods or related substances are present inside. Yekaterina Zinovieva, Deputy Prime Minister of Moscow Oblast and Minister of Investment, Industry and Science, stated that deploying such systems is one of the measures in the region to enhance the safety of cargo storage and transportation at container yards...

2026-08-07

Institute of Radiation Medicine, Chinese Academy of Medical Sciences Hosts Academic Seminar on PSMA-Targeted Radiopharmaceuticals

On August 3, the Institute of Radiation Medicine, Chinese Academy of Medical Sciences held an academic seminar, inviting Professor Lin Guoxian from the BC Cancer Agency in Vancouver, Canada, to deliver a lecture titled "Development of Prostate-Specific Membrane Antigen-Targeted Radiopharmaceuticals for the Diagnosis and Treatment of Prostate Cancer." The seminar was held in a hybrid format, with some researchers and graduate students from the institute attending in person. Professor Lin Guoxian has long been engaged in the development of targeted radiopharmaceuticals for cancer diagnosis and therapy, having led or contributed to the publication of over 135 peer-reviewed journal articles, filed more than 30 patent applications related to radiopharmaceuticals, and completed clinical translation of 7 self-developed radiopharmaceuticals applied in...

2026-08-07

Hu Jinjun, Member of the Standing Committee of the Guangdong Provincial Party Committee and Head of the Publicity Department, Conducts Research in Huizhou: Advancing Marine Economy Toward High-Quality Development by Leveraging the Sea

Recently, Hu Jinjun, Member of the Standing Committee of the Guangdong Provincial Party Committee and Head of the Publicity Department, conducted research in Huizhou, emphasizing the need to thoroughly study and implement General Secretary Xi Jinping's important expositions on promoting high-quality development of the marine economy, implement the provincial party committee's deployment requirements, orderly advance post-disaster recovery from Severe Typhoon Hongxia, consolidate the foundation during resumption of work and production, adhere to leveraging the sea for strength, and accelerate the high-quality development of the marine economy. Hu Jinjun and his delegation visited Guangdong Huangjing Marine Biotechnology Co., Ltd., Haozhaolou Wetland Park, the two major scientific facilities of the Chinese Academy of Sciences, CGN Taipingling Nuclear Power Station, and Unilumin Technology Huizhou Daya Bay Science and Technology Park, among other sites, to learn about the protection of Chinese bahaba germplasm resources and innovation in the southern sea large yellow croaker seed industry, marine ecological protection, commercialization of achievements from major scientific facilities, construction and operation of major energy projects, and R&D and manufacturing of cultural equipment, expressing recognition for the relevant work.

2026-08-07

DUNE Integrates Artificial Intelligence into Neutrino Experiment to Enhance Particle Detection and Data Processing Capabilities

The team at the U.S. Fermi National Accelerator Laboratory is advancing the Deep Underground Neutrino Experiment (DUNE) by integrating artificial intelligence and machine learning tools into experiment design, detector operations, and data analysis workflows, aiming to improve neutrino interaction identification, event classification, and detector management capabilities. Located at the Long-Baseline Neutrino Facility, DUNE has begun installing structural components for its large neutrino detector modules. The experiment consists of a near detector and a far detector: the near detector is situated at Fermilab, while the far detector is located approximately one mile underground at the Sanford Underground Research Facility in South Dakota. Both detectors will employ liquid argon time projection chamber technology to record neutrino...

2026-08-07

First Clinical Treatment Successfully Completed with China's Domestic Superconducting Cyclotron Proton Therapy System by CYC-Ion

On the morning of August 7, the domestically developed superconducting cyclotron proton therapy system, independently developed by Hefei CYC-Ion Medical Technology Equipment Co., Ltd., completed the first clinical trial treatment of a subject at Hefei Ion Medical Center. This marks a significant breakthrough as the first domestically produced superconducting cyclotron proton radiation therapy system in China. The subject in this case was a lung cancer patient. The superconducting proton therapy system used in the trial is equipped with the SC240 superconducting cyclotron independently developed by CYC-Ion, featuring an ultra-large irradiation field and 360° full-angle beam delivery capability. The entire treatment process relied on multi-modal fusion 4D image-guided precise positioning, enabling dynamic adaptation and precise treatment. The equipment operated smoothly with low noise, and the treatment control software ran...

2026-08-07

Indonesia's BRIN Showcases Nuclear Technology Research Progress, Covering Radiopharmaceuticals and Food Irradiation Applications

The National Research and Innovation Agency (BRIN) of Indonesia recently showcased its nuclear technology research achievements at the Presidential Palace in Jakarta. BRIN Head Arief Satria stated that the relevant technologies fall within the scope of peaceful uses of nuclear energy, with applications extending beyond energy to also cover food and health sectors. In the health sector, BRIN is developing radiopharmaceuticals for nuclear medicine. These drugs contain radioactive substances and can be used for cancer diagnosis and treatment. Arief stated that radiopharmaceutical research and development is of great significance for cancer detection and therapy. In the food sector, BRIN applies nuclear technology to food preservation, with a focus on irradiation treatment of export fruits. Arief explained that some importing countries re...

2026-08-07

American Fusion Adds Six New Patent Applications for Texatron Fusion Technology

On August 6, American Fusion announced that it has filed six new patent applications in the United States covering multiple technical aspects of its proprietary Texatron Fusion Engine platform. This brings the company's total number of patent applications filed in the U.S. to 82. American Fusion stated that these applications continue its strategy of building an intellectual property portfolio around the Texatron platform, covering reactor architecture, plasma confinement, electromagnetic systems, fuel delivery, reactor control, power management, and related engineering technologies supporting the continued development and future commercialization of the Texatron Fusion Engine. The company's Chief Legal Officer, Michael G....

2026-08-07

First Validation of Novel PRI Technology: Existing PET Tracers Can Image Tissue Microenvironment

August 6, 2026 - A joint research team from the Graduate School of Engineering at the University of Tokyo and the University of York in the UK announced that they have established a novel geometric imaging principle utilizing positron three-photon decay and successfully validated Positronium Ratio Imaging (PRI) technology for the first time. This method can be used in conjunction with existing clinical PET tracers and is expected to provide a new means of observing tissue microenvironments in nuclear medicine imaging. Conceptual diagram of next-generation nuclear medicine imaging utilizing positron-3-photon decay. Current clinical PET scans primarily rely on the positron two-photon annihilation process to visualize the distribution and accumulation of tracers in the body, but they provide limited information on microenvironmental factors such as tissue hypoxia that are associated with disease malignancy...

2026-08-07

Construction of Proton Therapy Center in Ulsan, South Korea Faces Hurdles: Government Funding Allocation Adjustments Impact Project Progress

The proton therapy center construction project in Ulsan, South Korea, has recently encountered obstacles to progress. The project was once regarded as a key component in improving the regional cancer treatment system in southeastern South Korea, but due to shifts in government medical financial support priorities, the difficulty of securing large-scale national funding independently has increased significantly. According to information from Ulsan City on August 6, Ulsan City completed the feasibility study and basic planning services for the proton therapy center construction in March of last year and began seeking national funding. However, the Ministry of Health and Welfare responded that it would be difficult to provide large-scale project funding to Ulsan City alone. Previously, Ulsan City had planned to establish a proton therapy center to build a system enabling cancer patients to undergo surgery...

2026-08-07

UK's MAST Upgrade sets plasma pressure record in fifth experimental campaign

The UK Atomic Energy Authority (UKAEA) has completed the fifth experimental campaign of its flagship fusion experiment, MAST Upgrade. The campaign, conducted between 2025 and 2026 at the Culham Campus in Oxfordshire, UK, produced over 1,100 plasma pulses and achieved the device's highest-ever plasma pressure while overcoming plasma instability issues. In fusion devices, hydrogen isotopes must be heated, compressed, and confined under extremely high temperatures and pressures. The higher the plasma density and temperature, the stronger the fusion reaction, and high-pressure plasmas are also closer to the operating conditions required for future commercial fusion power plants. UKAEA stated that this...

2026-08-07

IAEA Publishes Technical Document on Emergency Planning Zones for Small Modular Reactors

The International Atomic Energy Agency (IAEA) has published TECDOC Series No. 2134, "Technical Basis for the Emergency Planning Zone for Small Modular Reactors." The document was published in Vienna in 2026, comprising 132 pages with 11 illustrations, in English. This document marks the first time the IAEA has published the results of a Coordinated Research Project (CRP) on the technical basis for emergency planning zones for Small Modular Reactor (SMR) deployment. The research project was conducted from 2018 to 2021, focusing on how to determine the technical basis for off-site emergency preparedness and response (EPR) arrangements in SMR deployment scenarios, particularly the requirements and scope for establishing emergency planning zones (EPZ).

2026-08-07

Rosatom Completes First Batch of Certification for Energy Critical Information Infrastructure Products

Rosatom has recently completed the first batch of product certification for critical information infrastructure in the fuel and energy sector under the KII-Sert voluntary certification system. The certification system has been operating in Russia's nuclear energy and aerospace industries since 2024, primarily used to assess the reliability, technological independence, and sustainability of solutions related to critical information infrastructure. The certification was carried out by Atomenergoproekt JSC, part of Rosatom's engineering division. As an authorized certification body for trusted products and processes within the KII-Sert system, the company, in cooperation with the industrial testing laboratory Avtomatika-Servis LLC, certified a software and hardware system used in the oil and gas industry.

2026-08-07

Newcleo Initiates U.S. Regulatory Pre-Application Engagement for MOX Fuel Facility, Accelerating Advanced Reactor Fuel Supply Chain Development

Advanced reactor and nuclear fuel company Newcleo has initiated regulatory pre-application engagement with the U.S. Nuclear Regulatory Commission (NRC) for a mixed oxide (MOX) fuel fabrication facility, with plans to advance construction at the Savannah River Site in South Carolina. This move indicates that the company is not only advancing the licensing of its advanced reactor itself but also seeking to establish supporting fuel supply capabilities in parallel, aiming to mitigate fuel bottlenecks in future commercial deployment. The submitted regulatory engagement plan represents a key step prior to formal license application, with the core objective of communicating with regulators in advance on facility design, safety standards, review scope, and key technical issues. Newcleo previously submitted its regulatory engagement plan for the LFR-AS-200 lead-cooled fast reactor to the NRC in July...

2026-08-07

KHNP's "Integrated Nuclear Power Plant Maintenance Personnel Qualification System" Receives Official Government Recognition

On August 7, Korea Hydro & Nuclear Power (KHNP) announced that its integrated nuclear power plant maintenance personnel qualification system has officially received government recognition from the Korea Human Resource Development Service for Emerging Industries, an affiliate of the Ministry of Employment and Labor. This recognition signifies that the qualification system, used internally by the company to enhance employee job competencies, has received official confirmation in terms of evaluation standards, operational frameworks, and management mechanisms, providing a more credible institutional foundation for nuclear power plant equipment operation and maintenance capability building. The core of this recognized system lies in integrating the qualification frameworks previously operated separately by various nuclear maintenance partner companies into unified standards. This marks the first time such a standardized model has been established in Korea's nuclear maintenance sector...

2026-08-07